Announced
Completed
Synopsis
Xtant Medical, a medical technology company focused on surgical solutions for the treatment of spinal disorders, completed the acquisition of nanOss production operations from RTI Surgical, a leading CDMO in regenerative medicine. Financial terms were not disclosed. “nanOss is an important part of our total orthobiologics offering, and having full control over this product line enables us to begin the process of reviving and growing it. This deal satisfies each element of our acquisition criteria and positions us to improve our manufacturing capabilities, capacity and cash flows," Sean Browne, Xtant Medical CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.